HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative analysis of phosphatidylcholines and phosphatidylethanolamines in urine of patients with breast cancer by nanoflow liquid chromatography/tandem mass spectrometry.

Abstract
Phosphatidylcholines (PCs) and phosphatidylethanolamines (PEs) from urine of patients with breast cancer were qualitatively and quantitatively analyzed by nanoflow liquid chromatography-electrospray ionization tandem mass spectrometry (nLC-ESI-MS-MS). Urinary phospholipids (PLs) were extracted from three different categories of patients (non-cancer controls and breast cancer patients before and after surgery) by first lyophilizing only 1 mL of urine sample to enrich PLs. Next, nLC-ESI-MS-MS analysis of intact urinary phospholipids was performed, resulting in structural identification of 21 PCs and 12 PEs, followed by quantitative analysis using a multiple standard addition method. This study demonstrated that nLC-ESI-MS-MS can be powerfully utilized for the study of relative changes in the contents and concentration of urinary PCs and PEs from breast cancer patients: total concentration of PCs and PEs of patient sample increased to (144 +/- 9)% and (171 +/- 11)%, respectively, compared to control sample but they decreased significantly following surgery.
AuthorsHanna Kim, Hye Kyeong Min, Gu Kong, Myeong Hee Moon
JournalAnalytical and bioanalytical chemistry (Anal Bioanal Chem) Vol. 393 Issue 6-7 Pg. 1649-56 (Mar 2009) ISSN: 1618-2650 [Electronic] Germany
PMID19194696 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphatidylcholines
  • Phosphatidylethanolamines
Topics
  • Adult
  • Breast Neoplasms (urine)
  • Chromatography, Liquid (methods)
  • Female
  • Humans
  • Middle Aged
  • Phosphatidylcholines (urine)
  • Phosphatidylethanolamines (urine)
  • Spectrometry, Mass, Electrospray Ionization (methods)
  • Tandem Mass Spectrometry (methods)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: